Last updated: July 23, 2026

Does Cigna Cover Depression Treatment in Delaware? A 2026 Guide

If you have Cigna health insurance in Delaware and you are wondering whether your plan may cover depression treatment, the short answer is: Cigna commercial plans in Delaware are generally required to include behavioral health benefits that may cover depression care. Delaware’s mental health parity law, Del. Code Ann. tit. 18, § 3343, requires commercial fully-insured plans to cover mental health conditions, including depression, at parity with medical and surgical benefits. Understanding exactly what your plan may cover, how prior authorization works through Express Scripts (ESI), and what Delaware’s e-prescribing rules mean for telehealth can make a meaningful difference in accessing care.

Ready to connect with a licensed provider?

Klarity Health has 2,000+ licensed providers in Delaware and across the U.S. who accept Cigna and can evaluate and treat depression via telehealth.

See If You May Qualify. Check Your Coverage

Quick Facts: Cigna Depression Coverage in Delaware

• Insurer: Cigna Health and Life Insurance Company
• PBM (Pharmacy Benefits): Express Scripts (ESI)
• Delaware Parity Law: Del. Code Ann. tit. 18, § 3343. Applies to depression (covered MH condition)
• Cigna PA Policy IP0477: Stimulant-only (eff. May 15, 2026). Does NOT apply to antidepressants
• Delaware EPCS: Standard antidepressants are non-scheduled. EPCS entirely inapplicable. Spravato (esketamine, Schedule III): EPCS REQUIRED + REMS + TRD criteria
• Key contacts: Cigna Member Services 1-800-244-6224 | Express Scripts 1-800-835-3784 | Delaware Department of Insurance 1-302-674-7300

Delaware Mental Health Parity Law (§ 3343) and Depression

Delaware’s mental health parity statute, Del. Code Ann. tit. 18, § 3343, is a core protection for Delawareans with depression who have commercial, fully-insured health insurance through Cigna. The law is aligned with the federal Mental Health Parity and Addiction Equity Act (MHPAEA) and generally requires that:

• Financial requirements (copays, deductibles, out-of-pocket maximums) for mental health benefits, including depression treatment, cannot be more restrictive than those applied to substantially all medical and surgical benefits in the same classification.
• Treatment limitations (visit limits, day limits, frequency restrictions) cannot be more restrictive for mental health than for analogous medical benefits.
• Non-quantitative treatment limitations (NQTLs), such as prior authorization criteria, step therapy protocols, medical-necessity standards, and network adequacy, must be comparable in design and applied no more stringently for MH/SUD than for medical/surgical care.
• Telehealth: When depression care is delivered by telehealth, parity and plan design still apply. Delaware patients should confirm that their Cigna plan covers virtual psychiatric evaluation and medication management at the same cost-sharing level as in-person visits where the plan covers both modalities.

Important note for self-funded employer plans: If your Cigna coverage comes through a large employer that self-insures, Delaware’s § 3343 may not apply directly. Self-funded plans are governed by ERISA and federal MHPAEA. MHPAEA still provides federal parity protections. If you are unsure whether your plan is fully insured or self-funded, check your Summary Plan Description (SPD) or call Cigna at 1-800-244-6224. For ERISA plan issues, the U.S. Department of Labor EBSA can be reached at 1-866-444-3272.

What Depression Benefits May Be Available Under Cigna in Delaware

Most Cigna plans in Delaware that comply with § 3343 and the ACA may include the following depression-related benefits. Coverage varies by plan design, so always verify your own SBC and formulary.

• Outpatient therapy: Individual therapy, cognitive behavioral therapy (CBT), interpersonal therapy, and other evidence-based modalities for major depressive disorder (MDD) and related conditions
• Psychiatric evaluation and medication management: Initial diagnostic evaluation and ongoing prescription management with a licensed psychiatrist or psychiatric nurse practitioner
• Telehealth depression treatment: Virtual visits with licensed providers, when covered under your plan’s telehealth benefit
• Intensive outpatient programs (IOP) and partial hospitalization programs (PHP): For moderate-to-severe depression that needs more structure than weekly therapy
• Inpatient psychiatric hospitalization: For acute depressive episodes requiring 24-hour care
• ACA preventive services: Depression screening (PHQ-9 and similar tools) at no cost-sharing as a preventive service for adults, when delivered as required under the ACA
• Prescription drug coverage: Antidepressant medications managed through Express Scripts (see formulary section below)

Coverage varies by plan. Always verify your specific benefits by calling Cigna Member Services at 1-800-244-6224 or reviewing your Summary of Benefits and Coverage (SBC).

Explore online depression treatment options

Cigna PA Policy IP0477. Does It Apply to Depression Medications?

Cigna’s prior authorization policy IP0477 (effective May 15, 2026) requires prior authorization for all stimulant medications, including many generics. If you have read about IP0477 in relation to ADHD coverage under Cigna in Delaware, you may wonder whether it affects antidepressants. It does not.

IP0477 is a stimulant-only policy. It applies to stimulant medications such as amphetamine salts (Adderall), lisdexamfetamine (Vyvanse), methylphenidate (Ritalin, Concerta), and similar Schedule II controlled substances used primarily for ADHD. Standard antidepressants, including SSRIs, SNRIs, bupropion, mirtazapine, tricyclics, Auvelity, Trintellix, and MAOIs, are not subject to IP0477.

This distinction matters for Delaware patients seeking depression care. Your antidepressant prescription process under Cigna/ESI follows standard formulary tier, step therapy, and specialty PA rules, not the IP0477 stimulant protocol. Patients who were delayed by stimulant PA for ADHD should not assume the same friction applies to first-line depression medications.

Express Scripts (ESI) Antidepressant Formulary. Delaware 2026

Cigna uses Express Scripts (ESI) as its pharmacy benefits manager in Delaware. The table below outlines how common antidepressants are typically covered under ESI formulary tiers. Actual tier placement, quantity limits, and PA rules may vary by specific plan. Always confirm with ESI at 1-800-835-3784 or via the ESI online formulary tool.

Tier placements are estimates based on ESI standard formulary patterns for 2026. Your specific plan may differ. Call Express Scripts at 1-800-835-3784 to confirm tier, PA requirements, and step therapy criteria for your plan.

Delaware EPCS Rules for Antidepressants. What Telehealth Patients Need to Know

Delaware requires electronic prescribing of controlled substances (EPCS) for applicable schedules under Delaware Administrative Code Title 24 § 1700 and related controlled-substance rules. For most patients seeking depression treatment in Delaware, EPCS is not a barrier, because nearly all standard antidepressants are non-scheduled (not controlled substances).

Practical takeaway: For the vast majority of Delaware patients seeking depression treatment, including those on SSRIs, SNRIs, bupropion, mirtazapine, Trintellix, or Auvelity, Delaware’s EPCS requirement is entirely inapplicable. Telehealth providers can typically e-prescribe these medications without controlled-substance EPCS workflow. The primary exception is Spravato (esketamine), a Schedule III controlled substance that requires EPCS when prescribed, plus REMS-certified administration (not a take-home telehealth fill).

Note on Auvelity: Auvelity contains bupropion and dextromethorphan. As a combination product it remains non-scheduled for controlled-substance purposes, so Delaware EPCS does not apply. ESI may still require PA and documentation of prior antidepressant trials.

Spravato (Esketamine). Special Considerations Under Cigna/ESI

Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression (TRD), generally defined as major depressive disorder that has not adequately responded to at least two different antidepressant treatments of adequate dose and duration, and for major depressive disorder with acute suicidal ideation or behavior (MDSI).

Under Cigna/ESI in Delaware, Spravato coverage typically requires:

• Prior authorization (PA): Required before treatment. Cigna/ESI must approve based on clinical criteria.
• Step therapy / TRD documentation: Evidence of at least two adequate antidepressant trials (adequate dose and duration, often 6. 8 weeks each) that failed to produce sufficient response.
• REMS program: Spravato is subject to a Risk Evaluation and Mitigation Strategy (REMS). It must be administered in a certified healthcare setting with a minimum observation period (typically 2 hours). It cannot be taken at home or dispensed as a routine mail-order antidepressant.
• Delaware EPCS: Spravato is Schedule III. Prescribers in Delaware must use a compliant EPCS system when prescribing Spravato.
• Tier 4 specialty: Cost-sharing is usually at the specialty tier, often the highest pharmacy cost-sharing level before the out-of-pocket maximum.

Because REMS requires in-clinic administration and observation, Spravato is not a standard fully remote telehealth prescription even when the diagnostic evaluation begins online. If you believe you may qualify, ask your clinician about TRD documentation and whether a certified Spravato treatment site is accessible in Delaware or a nearby state.

Prior Authorization and Step Therapy for Antidepressants Under Cigna/ESI

Most generic first-line antidepressants (SSRIs, SNRIs, bupropion, mirtazapine) typically do not require prior authorization under standard ESI tiers and may be filled after your provider submits the prescription. Brand-name or newer agents more often trigger PA or step therapy.

Common situations that trigger PA or step therapy:

1. Trintellix (vortioxetine): Often requires documentation of a prior SSRI or SNRI trial.
2. Auvelity: Specialty-tier PA with clinical notes supporting diagnosis and prior treatment history is common.
3. Spravato: Specialty PA + REMS enrollment + TRD or MDSI criteria.
4. Brand products when a generic is preferred: Plans may require trial of the generic equivalent first.
5. High-dose or unusual quantity requests: Quantity limits may require clinical justification.

How to start a PA (typical 5 steps):

1. Your prescribing clinician submits the prescription and, if needed, the PA request through ESI/Cigna channels.
2. ESI reviews clinical criteria (diagnosis, prior trials, dosing, duration).
3. You or your clinician receive an approval, denial, or request for more information.
4. If approved, the pharmacy fills the medication under your plan’s cost-sharing rules.
5. If denied, request the denial reason in writing and proceed to appeal (see below), including peer-to-peer review when available.

How to Verify Your Cigna Depression Benefits in Delaware

Use this checklist before you rely on assumed coverage:

1. Call Cigna Member Services at 1-800-244-6224. Ask whether outpatient psychiatry, therapy, and telehealth for depression are covered on your specific plan, and what copay/coinsurance applies after deductible.
2. Confirm pharmacy benefits with Express Scripts at 1-800-835-3784. Ask about tier placement, PA, step therapy, and quantity limits for your exact medication and NDC if known.
3. Request your formulary and SBC. Review the mental health outpatient and pharmacy sections side by side.
4. Ask whether your plan is fully insured or self-funded. This determines whether Delaware § 3343 or primarily federal MHPAEA/ERISA applies.
5. Verify provider network status. Confirm that your chosen clinician or Klarity Health pathway is in-network or what out-of-network rules apply.

Verify benefits and see if you may qualify for care

How to Appeal a Denial of Depression Treatment or Medication

If Cigna or ESI denies depression treatment, a medication, or a PA request, Delaware patients generally have several pathways:

1. Internal appeal: Follow the appeal instructions on the denial letter within the stated deadline. Submit clinical notes, diagnosis codes, prior medication trials, and medical-necessity rationale.
2. Peer-to-peer (P2P) review: Ask your clinician to request a peer-to-peer discussion with a Cigna medical director when the denial is clinical in nature.
3. External review via Delaware Department of Insurance: For eligible fully insured plans, contact the Delaware Department of Insurance at 1-302-674-7300 about external review after internal appeals are exhausted (or earlier if expedited criteria apply).
4. Parity complaint under § 3343 / MHPAEA: If the denial appears more restrictive for mental health than for comparable medical benefits (for example, harsher PA or visit limits), raise a parity concern with the plan and, where applicable, the state DOI or federal regulators.
5. ERISA / DOL EBSA (self-funded plans): For employer self-funded plans, contact the U.S. Department of Labor EBSA at 1-866-444-3272. Medicare Advantage members follow CMS appeal rules rather than Delaware commercial external review.

Keep copies of all denial letters, EOBs, PA submissions, and clinician letters. Timelines are strict; missing a deadline can close a review path.

Cigna vs Other Delaware Insurers for Depression Coverage

If you are comparing plans during open enrollment, review each plan’s antidepressant formulary and behavioral health cost-sharing, not only the medical deductible.

Getting Depression Treatment Through Klarity Health With Cigna

Klarity Health connects patients with 2,000+ licensed providers who can evaluate depression symptoms, discuss treatment options, and, when clinically appropriate, prescribe non-controlled antidepressants via telehealth. Providers follow applicable Delaware prescribing rules. For Schedule III treatments such as Spravato, care is coordinated under REMS and EPCS requirements and is not a routine mail-order telehealth fill.

Klarity Health accepts major insurance including Cigna on many plans, and also offers cash-pay options. Coverage and network participation vary. Always verify benefits before your visit.

See If You May Qualify. Check Your Coverage

Frequently Asked Questions

Does Cigna cover depression treatment in Delaware?
Cigna commercial plans in Delaware typically include behavioral health benefits that may cover depression evaluation, therapy, and medication management, subject to your plan’s network rules, cost-sharing, and medical necessity. Delaware § 3343 and federal MHPAEA generally require parity with medical/surgical benefits for fully insured commercial plans. Always verify your specific plan.

Does Cigna PA policy IP0477 apply to antidepressants?
No. IP0477 (effective May 15, 2026) is a stimulant-only prior authorization policy. It does not apply to SSRIs, SNRIs, bupropion, mirtazapine, Trintellix, Auvelity, or other standard antidepressants.

Do I need EPCS for common antidepressants in Delaware?
No for standard antidepressants. SSRIs, SNRIs, bupropion, mirtazapine, TCAs, Trintellix, and Auvelity are non-scheduled, so Delaware EPCS does not apply. Spravato (esketamine) is Schedule III and requires EPCS, plus REMS-certified administration.

Who is the pharmacy benefit manager for Cigna in Delaware?
Express Scripts (ESI). Call 1-800-835-3784 for formulary, PA, and pharmacy claims questions.

What if my employer plan is self-funded?
Delaware § 3343 may not apply directly. Federal MHPAEA and ERISA generally govern. Contact Cigna for plan type confirmation and DOL EBSA at 1-866-444-3272 for ERISA questions.

Can I get depression care by telehealth with Cigna in Delaware?
Many Cigna plans cover telehealth behavioral health when the service is a covered benefit and the provider is eligible under the plan. Confirm telehealth cost-sharing and network status with Cigna at 1-800-244-6224. Klarity Health may be an option depending on your plan.

Key Contacts

• Cigna Member Services: 1-800-244-6224
• Express Scripts (ESI): 1-800-835-3784
• Delaware Department of Insurance: 1-302-674-7300
• U.S. Department of Labor EBSA (ERISA): 1-866-444-3272
• CMS (Medicare): 1-800-633-4227

Disclaimer

This guide is for educational purposes only and is not insurance advice, medical advice, or a guarantee of coverage. Insurance benefits, formularies, prior authorization criteria, and state rules change. Cigna and Express Scripts make final coverage determinations based on your specific plan documents. Always verify benefits with Cigna and ESI before scheduling care or filling prescriptions. Klarity Health providers exercise independent clinical judgment; not all patients are candidates for every medication or modality. Nothing on this page creates a provider. Patient relationship.

See If You May Qualify. Check Your Coverage